News From The Journal Of Clinical Investigation: March 8, 2010

Posted under Cancer by Cancer / Oncology News From Medical News Today

Warning sign for potential anticancer approach One treatment being investigated as an adjuvant for anticancer immunotherapies is the use of molecules that trigger the proteins TLR7 and TLR8. For example, the TLR7 stimulant imiquimod is used for the treatment of skin cancer and metastatic melanoma...

[ Read the whole story ]